XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Oct. 31, 2020 9,814,118      
Balance at Oct. 31, 2020 $ 98 $ 22,946 $ 9,020 $ 32,064
Exercise of stock options (in shares) 180,528      
Exercise of stock options $ 1 566 0 567
Stock-based compensation expense   634   634
Tax withholding related to vesting of restricted stock (in shares) (2,540)      
Tax withholding related to vesting of restricted stock   (13) 0 (13)
Consolidated net income     5,368 5,368
Issuance of restricted stock (in shares) 38,674      
Issuance of restricted stock $ 1 (1) 0 0
Forfeiture of restricted stock (in shares) (5,182)      
Shares (in shares) at Jul. 31, 2021 10,025,598      
Balance at Jul. 31, 2021 $ 100 24,132 14,388 38,620
Balance (in shares) at Apr. 30, 2021 10,001,056      
Balance at Apr. 30, 2021 $ 100 23,678 13,462 37,240
Exercise of stock options (in shares) 23,827      
Exercise of stock options $ 0 82 0 82
Stock-based compensation expense   374   374
Tax withholding related to vesting of restricted stock (in shares) (261)      
Tax withholding related to vesting of restricted stock $ 0 (2) 0 (2)
Consolidated net income $ 0 0 926 926
Issuance of restricted stock (in shares) 1,840      
Forfeiture of restricted stock (in shares) (864)      
Forfeiture of restricted stock   0 0 0
Shares (in shares) at Jul. 31, 2021 10,025,598      
Balance at Jul. 31, 2021 $ 100 24,132 14,388 38,620
Balance (in shares) at Oct. 31, 2021 10,058,571      
Balance at Oct. 31, 2021 $ 101 24,301 15,201 $ 39,603
Exercise of stock options (in shares) 60,854     60,854
Exercise of stock options $ 1 149   $ 150
Stock-based compensation expense   498   498
Tax withholding related to vesting of restricted stock (in shares) (2,900)      
Tax withholding related to vesting of restricted stock   (19)   (19)
Consolidated net income     997 997
Issuance of restricted stock (in shares) 39,666      
Issuance of restricted stock $ 0 0    
Shares (in shares) at Jul. 31, 2022 10,156,191      
Balance at Jul. 31, 2022 $ 102 24,929 16,198 41,229
Balance (in shares) at Apr. 30, 2022 10,118,685      
Balance at Apr. 30, 2022 $ 102 24,648 15,427 40,177
Exercise of stock options (in shares) 37,927      
Exercise of stock options $ 0 93 0 93
Stock-based compensation expense   191 0 191
Tax withholding related to vesting of restricted stock (in shares) (421)      
Tax withholding related to vesting of restricted stock   (3) 0 (3)
Consolidated net income     771 771
Shares (in shares) at Jul. 31, 2022 10,156,191      
Balance at Jul. 31, 2022 $ 102 $ 24,929 $ 16,198 $ 41,229